tert-Butyl 8-oxo-5-azaspiro[3.5]nonane-5-carboxylate, 95.0%, 5g

3-NEOPENTYLISOXAZOL-5-AMINE, 95.0%, 250mg

4-Chloro-2-iodobenzoic acid, 98.0%, 5g

2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium Chloride [for Biochemical Research]>98.0%(HPLC)100mg

N-METHYL-L-SERINE HYDROCHLORIDE, 95%, 5g

(S)-tert-Butyl 4,5-diamino-5-oxopentanoate, 97%, 100mg

Matraces aforados clase A Vidrio marrón, 1000 ml, 24/29, 1 unidad(es), 1 Pieza

Isoquinoline-4-carboxamide, 97%, 100mg

N*1*-(1,4-Dioxa-spiro[4.4]non-2-ylmethyl)-ethane-1,2-diamine, 98%, 1g

3-{[1,1'-biphenyl]-4-yl}-5-methyl-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

3-Methyl-6-(4-methyl-3-nitrophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-amine, 97%, 100mg

Monoclonal de ratón con etiqueta anti-DDDDK, AP1501, 25 µg

4,4'-(2,2-Bis(4-methoxyphenyl)ethene-1,1-diyl)dibenzaldehyde, 95%, 1g